<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03123796</url>
  </required_header>
  <id_info>
    <org_study_id>332</org_study_id>
    <nct_id>NCT03123796</nct_id>
  </id_info>
  <brief_title>Effects of Proton Pump Inhibitors on Kidney Transplant Recipients</brief_title>
  <official_title>Effects of Proton Pump Inhibitors on Kidney Transplant Recipients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Istanbul University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Istanbul University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Use of proton pump inhibitors (PPIs) is quite common among renal transplant recipients and
      reduced kidney functions and hypomagnesemia with the use of PPIs have been reported. In this
      study, investigation of the effects of PPI use on the outcome of kidney transplant recipients
      is aimed.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Use of proton pump inhibitors (PPIs) is frequent among renal transplant recipients due to the
      common use of glucocorticoids in immunosuppresive regimens after transplantation. Reduced
      kidney functions and hypomagnesemia with the use of PPIs have been reported in various
      patient populations. However, few studies examined the effects of PPIs on kidney transplant
      recipients. Therefore, the aim of this study is to investigate the effects of PPI and/or
      histamine H2 receptor antagonist use on serum magnesium levels, allograft functions and
      survival in kidney transplant recipients.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">December 2016</start_date>
  <completion_date type="Actual">November 2017</completion_date>
  <primary_completion_date type="Actual">September 2017</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Graft survival</measure>
    <time_frame>5-10 years</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Graft rejection</measure>
    <time_frame>5-10 years</time_frame>
  </secondary_outcome>
  <other_outcome>
    <measure>Serum magnesium levels</measure>
    <time_frame>5-10 years</time_frame>
  </other_outcome>
  <number_of_groups>4</number_of_groups>
  <enrollment type="Actual">300</enrollment>
  <condition>Transplant Dysfunction</condition>
  <condition>Magnesium Disorder</condition>
  <arm_group>
    <arm_group_label>Only PPI</arm_group_label>
    <description>Kidney transplant recipients who used only proton pump inhibitors and did not use histamine H2 receptor antagonists.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Only H2RA</arm_group_label>
    <description>Kidney transplant recipients who used only histamine H2 receptor antagonists and did not use proton pump inhibitors.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>PPI and H2RA</arm_group_label>
    <description>Kidney transplant recipients who used both proton pump inhibitors and histamine H2 receptor antagonists.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>No Acid Suppressive Treatment</arm_group_label>
    <description>Kidney transplant recipients who used neither proton pump inhibitors nor histamine H2 receptor antagonists.</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Kidney transplant recipients.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Kidney transplant recipients who used only proton pump inhibitors and did not use
             histamine H2 receptor antagonists (Only PPI).

          -  Kidney transplant recipients who used histamine H2 receptor antagonists and did not
             use proton pump inhibitors (Only H2RA).

          -  Kidney transplant recipients who used both proton pump inhibitors and histamine H2
             receptor antagonists (PPI and H2RA).

          -  Kidney transplant recipients who used neither proton pump inhibitors nor histamine H2
             receptor antagonists (No Acid Suppressive Treatment).

        Exclusion Criteria:

          -  Patients who are unwilling or unable to consent.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Yasar Caliskan, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Division of Nephrology, Department of Internal Medicine, Istanbul Faculty of Medicine</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Division of Nephrology, Department of Internal Medicine, Istanbul Faculty of Medicine</name>
      <address>
        <city>Ä°stanbul</city>
        <zip>34093</zip>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <reference>
    <citation>Lazarus B, Chen Y, Wilson FP, Sang Y, Chang AR, Coresh J, Grams ME. Proton Pump Inhibitor Use and the Risk of Chronic Kidney Disease. JAMA Intern Med. 2016 Feb;176(2):238-46. doi: 10.1001/jamainternmed.2015.7193.</citation>
    <PMID>26752337</PMID>
  </reference>
  <reference>
    <citation>van Boekel GA, Kerkhofs CH, van de Logt F, Hilbrands LB. Proton pump inhibitors do not increase the risk of acute rejection. Neth J Med. 2014 Feb;72(2):86-90.</citation>
    <PMID>24659591</PMID>
  </reference>
  <verification_date>December 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 19, 2017</study_first_submitted>
  <study_first_submitted_qc>April 19, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">April 21, 2017</study_first_posted>
  <last_update_submitted>December 25, 2017</last_update_submitted>
  <last_update_submitted_qc>December 25, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">December 27, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Istanbul University</investigator_affiliation>
    <investigator_full_name>Yasar Caliskan</investigator_full_name>
    <investigator_title>Associate Professor of Medicine</investigator_title>
  </responsible_party>
  <keyword>chronic rejection</keyword>
  <keyword>transplant outcome</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Proton Pump Inhibitors</mesh_term>
    <mesh_term>Histamine H2 Antagonists</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

